Related content

Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol

By Rahamimov R.   Yussim A.   After T.   Lustig S.   Bar-Nathan N.   Shaharabani E.   Shapira Z.   Shabthai E.   Mor E.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 653-654

Elsevier

Access to resources Recommend Favorite

Use of Tacrolimus and Mycophenolate Mofetil For Pancreas-Kidney Transplantation With or Without OKT3 Induction

By Burke G.W.   Ciancio G.   Alejandro R.   Roth D.   Ricordi C.   Tzakis A.   Miller J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1544-1545

Elsevier

Access to resources Recommend Favorite

Contribution of mycophenolate mofetil after withdrawal of cyclosporine to toxicity in kidney transplantation

By Hazzan M.   Bourdon F.   Dracon M.   Lelievre G.   Noel C.  

Transplantation Proceedings, Vol. 30, Iss. 6, 1998-09 ,pp. : 2809-2810

Elsevier

Access to resources Recommend Favorite

-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression

By Folkmane I.   Chapenko S.   Amerika D.   Bicans J.   Murovska M.   Rosentals R.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2384-2385

Elsevier

Access to resources Recommend Favorite

Simultaneous Pancreas/Kidney Transplantation: Comparison of Mycophenolate Mofetil Versus Azathioprine

By Elkhammas E.A.   Yilmaz S.   Henry M.L.   Yenchar J.   Bumgardner G.L.   Pelletier R.P.   Ferguson R.M.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 512-512

Elsevier

Access to resources Recommend Favorite